CD300a Antikörper (APC)

Produktnummer ABIN6240821

Produktdetails anti-CD300a Antikörper (APC)

Target: CD300a (CD300A)

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser CD300a Antikörper ist konjugiert mit APC

Applikation: Flow Cytometry (FACS)

Spezifität: The antibody MEM-260 reacts with an extracellular epitope of CD300a, a 60 kDa leukocyte transmembrane glycoprotein expressed on human granulocytes, monocytes, neutrophils, NK cells, mast cells and dendritic cells, 25 % of circulating T cells and 15 % of circulating B cells.

Kreuzreaktivität (Details): Human

Aufreinigung: Purified antibody is conjugated with activated allophycocyanin (APC) under optimum conditions and unconjugated antibody and free fluorochrome are removed by size-exclusion chromatography.

Immunogen: HPB human acute lymphoid leukemia cell line

Klon: MEM-260

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise: Flow cytometry: The reagent is designed for analysis of human blood cells using 10 μL reagent / 100 μL of whole blood or 10⁶ cells in a suspension. The content of a vial (1 ml) is sufficient for 100 tests.

Kommentare:

The purified antibody is conjugated with cross-linked Allophycocyanin (APC) under optimum conditions. The conjugate is purified by size-exclusion chromatography and adjusted for direct use. No reconstitution is necessary.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Buffer: Stabilizing phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: The purified antibody is conjugated with cross-linked Allophycocyanin (APC) under optimum conditions. The conjugate is purified by size-exclusion chromatography and adjusted for direct use. No reconstitution is necessary.

Lagerung: 4 °C

Informationen zur Lagerung: Store at 2-8°C. Protect from prolonged exposure to light. Do not freeze.

Details zu CD300a

Target: CD300a (CD300A)

Andere Bezeichnung: CD300a (CD300A Produkte)

Synonyme: CD300L-B1 antikoerper, CD300A antikoerper, clm8 antikoerper, B230315M08Rik antikoerper, Clm8 antikoerper, LMIR1 antikoerper, MAIR-I antikoerper, MAIR-Ia antikoerper, MMAC8 antikoerper, Pigr4 antikoerper, mcpir1 antikoerper, CLM-8 antikoerper, CMRF-35-H9 antikoerper, CMRF-35H antikoerper, CMRF35-H antikoerper, CMRF35-H9 antikoerper, CMRF35H antikoerper, CMRF35H9 antikoerper, IGSF12 antikoerper, IRC1 antikoerper, IRC1/IRC2 antikoerper, IRC2 antikoerper, IRp60 antikoerper, CD300 molecule like family member g antikoerper, CD300a molecule antikoerper, CMRF35-like molecule 8 antikoerper, CD300A molecule antikoerper, Cd300a molecule antikoerper, CD300LG antikoerper, CD300A antikoerper, LOC483289 antikoerper, clm8 antikoerper, Cd300a antikoerper

Hintergrund: CD300a molecule,CD300a (CMRF-35H, IRp60) is a non-MHC-specific inhibitory receptor of immunoglobulin superfamily, which contains three immunoreceptor tyrosine-based inhibitory motifs (ITIMs) that associate with SH2-containing phosphatases SHP-1 and SHP-2. CD300a is expressed on many cell types including T cells, NK cells, neutrophils, eosinophils or mast cells. Its triggering inhibits activating signals such as those of IL5, GM-CSF or eotaxin, as well as supresses mast cell degranulation or NK cell cytotoxic activity.,IRC, CLM-8, IGSF12, CMRF35H

Gen-ID: 11314

UniProt: Q9UGN4

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process